The Impact of Telemedicine on Patients with Hidradenitis Suppurativa in the COVID-19 Era

被引:2
|
作者
Gierek, Marcin [1 ]
Kitala, Diana [1 ]
Labus, Wojciech [1 ]
Glik, Justyna [1 ,2 ]
Szyluk, Karol [3 ,4 ]
Pietrauszka, Kornelia [5 ]
Bergler-Czop, Beata [5 ]
Niemiec, Pawel [6 ]
机构
[1] Dr Sakiel Ctr Burns Treatment, Jana Pawla 2Street 2, PL-41100 Siemianowice Slaskie, Poland
[2] Med Univ Silesia, Fac Hlth Sci Katowice, Dept Org Chron Wound Healing, PL-40055 Katowice, Poland
[3] Med Univ Silesia, Fac Hlth Sci Katowice, Dept Physiotherapy, PL-40752 Katowice, Poland
[4] Dist Hosp Orthopaed & Trauma Surg, Bytomska 62 St, PL-41940 Piekary Slaskie, Poland
[5] Med Univ Silesia, Dept Dermatol, Francuska St, PL-40027 Katowice, Poland
[6] Med Univ Silesia, Sch Hlth Sci Katowice, Dept Biochem & Med Genet, Medykow St 18, PL-40752 Katowice, Poland
关键词
hidradenitis suppurativa; acne inversa; telemedicine; teleconsultation; teledermatology; telehealth; COVID-19; healthcare;
D O I
10.3390/healthcare11101453
中图分类号
R19 [保健组织与事业(卫生事业管理)];
学科分类号
摘要
(1) Background: Hidradenitis suppurativa is a chronic, inflammatory skin disease. It is characterized by the transformation of normal skin into skin with abscesses, nodules, tunnels, and scars. The most commonly affected areas are the armpits, groins, buttocks, and subscapular area. Patients with HS require constant care under the supervision of the outpatient clinic. Due to the COVID-19 pandemic, consultations have been introduced in the form of telemedicine. The aim of this study was to evaluate the availability of HS treatment during the COVID-19 pandemic and to assess patient satisfaction, problems with access to medical care, and the impact of the pandemic on the course of the disease. (2) Methods: An internet survey with an anonymous questionnaire was used to assess the effectiveness of telemedicine consultations. The survey consisted of 25 closed questions, and responses were kept fully anonymous. (3) Results: Most respondents reported minor problems with accessing specialized HS medical care during the COVID-19 pandemic (n = 25, 35.71%). However, 35.71% (n = 25) of them reported major problems with appointments for specialized ambulatory treatment during the last few months of the pandemic, mainly due to delayed appointments. Almost half of the respondents had been diagnosed with COVID-19 (n = 34, 48.57%), and 58.57% (n = 41) of respondents did not see a correlation between COVID-19 infection and HS progression. (4) Conclusions: Our study showed that the pandemic significantly limited access to medical advice, and patients with hidradenitis suppurativa prefer standard consultations.
引用
收藏
页数:12
相关论文
共 50 条
  • [1] Hidradenitis suppurativa and adalimumab in the COVID-19 era
    Marzano, Angelo Valerio
    Moltrasio, Chiara
    Genovese, Giovanni
    Muratori, Simona
    Dapavo, Paolo
    Fabbrocini, Gabriella
    Patrizi, Annalisa
    Sechi, Andrea
    Micali, Giuseppe
    Pellegrino, Michele
    Gisondi, Paolo
    Dini, Valentina
    Bianchi, Luca
    Fania, Luca
    Offidani, Annamaria
    Prignano, Francesca
    Atzori, Laura
    Miraglia, Emanuele
    Cannavo, Serafinella Patrizia
    Bettoli, Vincenzo
    Stingeni, Luca
    Balestri, Riccardo
    Venturini, Marina
    Peris, Ketty
    EUROPEAN JOURNAL OF DERMATOLOGY, 2020, 30 (06) : 748 - 749
  • [2] Hidradenitis suppurativa and adalimumab in the COVID-19 era
    Angelo Valerio Marzano
    Chiara Moltrasio
    Giovanni Genovese
    Simona Muratori
    Paolo Dapavo
    Gabriella Fabbrocini
    Annalisa Patrizi
    Andrea Sechi
    Giuseppe Micali
    Michele Pellegrino
    Paolo Gisondi
    Valentina Dini
    Luca Bianchi
    Luca Fania
    Annamaria Offidani
    Francesca Prignano
    Laura Atzori
    Emanuele Miraglia
    Serafinella Patrizia Cannavò
    Vincenzo Bettoli
    Luca Stingeni
    Riccardo Balestri
    Marina Venturini
    Ketty Peris
    European Journal of Dermatology, 2020, 30 : 748 - 749
  • [3] Impact of COVID-19 pandemic on hidradenitis suppurativa patients
    Horvath, Barbara
    Bouwman, Klasiena S.
    EXPERIMENTAL DERMATOLOGY, 2022, 31 : 94 - 94
  • [4] Impact of the COVID-19 pandemic on patients with hidradenitis suppurativa
    Fiocco, Zeno
    Schlager, Justin Gabriel
    Kendziora, Benjamin
    Patzak, Leilah
    Kupf, Sophie
    French, Lars Einar
    Hartmann, Daniela
    INTERNATIONAL WOUND JOURNAL, 2022, 19 (07) : 1686 - 1692
  • [5] COVID-19 in patients with hidradenitis suppurativa
    Lima, X. T.
    Cueva, M. A.
    Alora, M. B.
    BRITISH JOURNAL OF DERMATOLOGY, 2021, 184 (01) : 182 - 184
  • [6] Remote management of hidradenitis suppurativa in a pandemic era of COVID-19
    Kang, Na-Young C.
    Hsiao, Jennifer
    Shi, Vivian
    Naik, Haley B.
    Lowes, Michelle A.
    Alavi, Afsaneh
    INTERNATIONAL JOURNAL OF DERMATOLOGY, 2020, 59 (09) : E318 - E320
  • [7] Impact of COVID-19 infection on hidradenitis suppurativa activity
    Torpey, M. E.
    Nosrati, A.
    Campton, K. L.
    Cohen, S. R.
    JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2022, 142 (08) : S46 - S46
  • [8] Experience in patients with hidradenitis suppurativa and COVID-19 symptoms
    Luis Galan, Jose
    Silvente, Catiana
    Gonzalez, Monica
    Garcia, Claudia
    Diez, Kevin
    Angeles Martin, Maria
    Velazquez, Diana
    de la Cueva, Pablo
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2020, 83 (04) : E309 - E311
  • [9] Incidence of COVID-19 hospitalization in patients with hidradenitis suppurativa
    Koptyev, Jonathan
    Strunk, Andrew
    Garg, Amit
    EXPERIMENTAL DERMATOLOGY, 2022, 31 : 94 - 94
  • [10] The experience of COVID-19 and its impact on management of hidradenitis suppurativa
    Benesh, Gabrielle
    Andriano, Tyler M.
    Babbush, Kayla M.
    Cohen, Steven R.
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2021, 85 (03) : AB9 - AB9